🇺🇸 FDA
Company

Cyclerion

Cyclerion Therapeutics

CYCN pharma USA

Quick answer

Cyclerion is a pharma company (CYCN) headquartered in CAMBRIDGE, MA, USA with 9 tracked pipeline programs.

Pipeline (9)

project

IW-1701

Sickle Cell Disease

Phase 2 · small_molecule · completed

1 trials project

IW-1973

Diabetes Mellitus, Type 2

Phase 2 · small_molecule · completed

1 trials project

Matching Placebo

Diabetes Mellitus, Type 2

Phase 2 · small_molecule · completed

1 trials project

Olinciguat

Achalasia

Phase 2 · small_molecule · terminated

1 trials project

IW-1701

Healthy

Phase 1 · small_molecule · completed

2 trials project

IW-1973

Healthy

Phase 1 · small_molecule · completed

2 trials project

Olinciguat

Healthy

Phase 1 · small_molecule · completed

1 trials project

[14C]-olinciguat

Healthy Volunteers

Phase 1 · small_molecule · completed

1 trials project

[14C]-praliciguat

Healthy Volunteers

Phase 1 · small_molecule · completed

1 trials

Patents (8)

patent

US 12247025

Processes for preparation of soluble guanylate cyclase stimulators

Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11834444

Processes for preparation of soluble guanylate cyclase stimulators

Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11731977

SGC stimulators

Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11690828

Treatment of CNS diseases with sGC stimulators

Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11572358

Solid forms of an sGC stimulator

Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11466015

Crystalline forms of 8-(2-fluorobenzyl)-6-(3-(trifluoromethyl)-1H-1,2,4-triazol-

Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11389449

Treatment of metabolic syndrome with an sGC stimulator

Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11357777

Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)

Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)